Creatine kinase elevation: a neglected clue to the diagnosis of polymyositis. A case report

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Epigenetics in cancer: a promising path to follow?
4. Reviews
5. The circulating miRNAs as diagnostic and prognostic markers
6. Analytical barriers in clinical B-type natriuretic peptide measurement and the promising analytical methods based on mass spectrometry technology
7. Mini Review
8. Commutability of reference and control materials: an essential factor for assuring the quality of measurements in Laboratory Medicine
9. EFLM Paper
10. Preanalytical challenges – time for solutions
11. General Clinical Chemistry and Laboratory Medicine
12. Iron status determination in individuals with Helicobacter pylori infection: conventional vs. new laboratory biomarkers
13. Harmonizing by reducing inter-run variability: performance evaluation of a quality assurance program for antinuclear antibody detection by indirect immunofluorescence
14. Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors
15. Accuracy of determination of the glomerular filtration marker iohexol by European laboratories as monitored by external quality assessment
16. Therapeutic drug monitoring (TDM) of 5-fluorouracil (5-FU): new preanalytic aspects
17. Monitoring the effectiveness of hypothermia in perinatal asphyxia infants by urinary S100B levels
18. Hematology and Coagulation
19. Determination of haemoglobin derivatives in aged dried blood spot to estimate haematocrit
20. Reference Values and Biological Variations
21. A study of biological and lifestyle factors, including within-subject variation, affecting concentrations of growth differentiation factor 15 in serum
22. Reference intervals for thyroid-stimulating hormone, free thyroxine, and free triiodothyronine in elderly Chinese persons
23. Cancer Diagnostics
24. Extracellular vesicle-associated miRNAs in ovarian cancer – design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance
25. Evaluating the diagnostic and prognostic value of serum long non-coding RNA CTC-497E21.4 in gastric cancer
26. A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers
27. Cardiovascular Diseases
28. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS
29. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction
30. Diabetes
31. Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio
32. Letters to the Editor
33. The search for a new test of early cancer detection
34. Need of a dedicated isotopic internal standard for accurate 3-epi-25(OH)D3 quantification by LC-MS/MS
35. An unexpectedly prolonged severe hyperbilirubinemia in a patient with pre-existing hepatitis A: a role of genetic predisposition?
36. Creatine kinase elevation: a neglected clue to the diagnosis of polymyositis. A case report
37. Analytical performance of the new Siemens NT-proBNP assays on the Advia Centaur XPT compared to the NT-proBNP method on the Dimension Vista
38. Free PAPP-A as a biomarker: heparin-induced release is not related to coronary atherosclerotic burden
39. Anti-citrullinated protein antibodies are not associated with extent of disease or prognosis in patients with coronary artery disease
40. A new preanalytical factor: conveyor transport influences residual platelet concentrations
41. Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry
42. Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio